Cargando…
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials
Adolescent and young adults (AYAs) with acute lymphoblastic leukemia (ALL) treated with asparaginase-containing pediatric regimens are commonly overweight or obese. We studied the association of body mass index (BMI) on outcomes of 388 AYAs aged 15 to 50 years treated on Dana-Farber Cancer Institute...
Autores principales: | Shimony, Shai, Flamand, Yael, Valtis, Yannis K., Place, Andrew E., Silverman, Lewis B., Vrooman, Lynda M., Brunner, Andrew M., Sallan, Stephen E., Stone, Richard M., Wadleigh, Martha, Neuberg, Donna S., DeAngelo, Daniel J., Luskin, Marlise R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500474/ https://www.ncbi.nlm.nih.gov/pubmed/37432068 http://dx.doi.org/10.1182/bloodadvances.2023009976 |
Ejemplares similares
-
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials
por: Valtis, Yannis K., et al.
Publicado: (2021) -
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
por: Shimony, Shai, et al.
Publicado: (2022) -
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years
por: Shimony, Shai, et al.
Publicado: (2023) -
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
por: Tran, Thai Hoa, et al.
Publicado: (2022) -
Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic
por: Raman, Hari S., et al.
Publicado: (2021)